Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | iSCIB1+ |
| Synonyms | |
| Therapy Description |
iSCIB1+ is a DNA vaccine that consists of TRP2/gp100 epitopes and a modified Fc that covers multiple HLA haplotypes, which may lead to enhanced anti-tumor immune response (Cancer Res (2026) 86 (8_Supplement): CT237). |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| iSCIB1+ | iSCIB1+ is a DNA vaccine that consists of TRP2/gp100 epitopes and a modified Fc that covers multiple HLA haplotypes, which may lead to enhanced anti-tumor immune response (Cancer Res (2026) 86 (8_Supplement): CT237). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|